Recruiting
Phase 2

Stop-Smoking Program

Sponsor:

University of Vermont

Code:

NCT00865553

Conditions

Tobacco Use Disorder

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

computer-assisted smoking cessation intervention

cancer prevention

educational intervention

survey administration

Study Details

Brief summary:

RATIONALE: A computer-assisted stop-smoking program may help doctors counsel patients who smoke and may help increase the number of patients who stop smoking.

PURPOSE: This phase II trial is studying how well a computer-assisted stop-smoking program works in helping doctors counsel patients who smoke cigarettes.

Conditions

Tobacco Use Disorder

Study ID

NCT00865553

Start date

Mar, 2009

Status verified date

Mar, 2011

Primary completion date

Aug, 2010

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

DISEASE CHARACTERISTICS:

  • Current smoker, defined as self-reported smoking most days or every day (patient)
  • Seeks care at a participating Fletcher Allen Health Care primary care clinic (patient)

PATIENT CHARACTERISTICS:

  • Not specified

PRIOR CONCURRENT THERAPY:

  • Not specified

Study Design

Enrollment

630 participants

Anticipated

Primary purpose

Health Services Research

Interventions and Outcome Measures

Interventions

computer-assisted smoking cessation intervention

cancer prevention

educational intervention

survey administration

Primary outcome measure

  • Physician adherence to the United States Public Health Service's Tobacco Use and Dependence Treatment guideline (USPHS Guideline) as measured by the patient exit survey [ Time Frame: undefined ]
  • Patient perception of physician as measured by the patient exit survey and telephone interview [ Time Frame: undefined ]
  • Prevalence of smoking and associated variables as measured by the patient exit survey [ Time Frame: undefined ]
  • Patient interaction with the smoking cessation-personal digital assistant (SC-PDA) as measured by the patient exit survey and telephone interview [ Time Frame: undefined ]
  • Patient report of physician SC-PDA use as measured by the patient exit survey and telephone interview [ Time Frame: undefined ]
  • Aggregate data on accessing SC-PDA screens by each physician as measured by the SC-PDA server log [ Time Frame: undefined ]
  • Generation of patient handouts as measured by the SC-PDA server log, clinic staff focus groups, and telephone interview [ Time Frame: undefined ]
  • Physician self-reported use of SC-PDA as measured by physician interview [ Time Frame: undefined ]
  • Physician opinion on perceived value and barriers to use as measured by physician interview [ Time Frame: undefined ]
  • Clinic staff opinion on the effect of SC-PDA on clinic workflow as measured by clinic staff focus groups [ Time Frame: undefined ]

Central Contacts and Locations

Locations

Vermont Cancer Center at University of Vermont

Recruiting

Burlington, Vermont, United States, 05405-0110

Contacts

Clinical Trials Office - Vermont Cancer Center at University o

802-656-2178

More Information

Sponsor

University of Vermont

Last update posted

Sep 20, 2013

Last verified

Mar, 2011

Keywords

  • tobacco use disorder

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Vermont on 2013-09-20.